Service by

Home Journal Issues Guide for Authors Editorial Board About Journal Aims & Scope


Original Research Open Access
NJIRM. 2013; 4(2): 128-133


Role Of Antioxidant Therapy In Management Of Type 2 Diabetes Mellitus

N K Desai*, P H Bhabhor*, D Domadia*, J D Bhatt**.

Abstract
Introduction: Diabetes Mellitus is a heterogeneous group of disorders characterized by variable degrees of insulin resistance, impaired insulin secretion and increased glucose production. Free radical injury is important contributing factor for the development of Insulin resistance and impaired insulin secretion. Recently it has been suggested that glycation of antioxidant enzymes could alter the structure and function of antioxidant enzymes such that they are unable to detoxify free radicals. Intake of vitamin E and vitamin C, due to antioxidant property, is associated with reduced risk of development of Diabetes Mellitus Type 2. With this background, this study was planned to explore the role of antioxidant therapy in the management of Diabetes Mellitus Type 2. Objectives: (1) To demonstrate increased oxidative stress in newly diagnosed Type 2 Diabetes Mellitus patients by measuring antioxidant enzymes activities. (2) To study the effect of oral hypoglycaemic agents on oxidative stress in Type 2 Diabetes Mellitus patients. (3) To evaluate the effects of vitamin C, vitamin E and their combination in patients having Type 2 Diabetes Mellitus managed with oral hypoglycaemic agents. Materials and Methods: The study included two groups consisting of 60 euglycemic healthy subjects and 64 newly diagnosed Diabetes Mellitus Type 2 patients. After 3 months of treatment with oral hypoglycaemic drug, the second group was divided into 4 subgroups with 16 subjects in each subgroup and were treated with oral hypoglycaemic agent alone, oral hypoglycaemic agent + vitamin C, oral hypoglycaemic agent + vitamin E, and oral hypoglycaemic agent + vitamin C + vitamin E respectively for further 3 months. Results : Hyperglycemia in patients with Diabetes Mellitus Type 2 is associated with reduced antioxidant status (superoxide dismutase and catalase activities, and reduced glutathione level). Treatment with oral hypoglycaemic agent for 3 months produced euglycemia with partial but statistically significant elevation of catalase activity and reduced glutathione level in blood. Following additional antioxidant therapy with vitamin C and vitamin E produced further significant increase in reduced glutathione level, however fasting plasma glucose level and activities of superoxide dismutase and catalase enzymes were found to be statistically non-significant.Conclusion: Antioxidant therapy with vitamin C and vitamin E in addition to oral hypoglycaemic agent reduces oxidative stress in patients having Type 2 Diabetes Mellitus [Desai N K et al NJIRM 2013; 4(2) : 128-133]

Key words: Type 2 Diabetes Mellitus , Vitamin C, Vitamin E, Antioxidant


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by N K Desai*
Articles by P H Bhabhor*
Articles by D Domadia*
Articles by J D Bhatt**
on Google
on Google Scholar
Article Statistics
 Viewed: 4268
Downloaded: 1181
Cited: 0


REFERENCES
1. Powers A. C. Diabetes mellitus. In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL, eds. Harrison's Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2005: 2152 – 2180.
2. Wiernsperger N.F. Oxidative stress as a therapeutic target in diabetes : revisiting the controversy. Diabetes Metab, 2003, 29 : 579 – 585. [DOI via Crossref]   
3. E. Wright et al. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. International journal of clinical practice, Vol. 60, No. 3. (March 2006), pp. 308-314. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
4. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Are oxidative stress activated signaling pathways mediators of insulin resistance and β – cell dysfunction ? Diabetes, 2003, 52 : 1 – 8. [DOI via Crossref]    [Pubmed]   
5. Robertson R.P., Jamie Harmon, Phuong O.T., Yoshito Tanaka, and Hiroki Takahashi. Glucose toxicity in β- cells : Type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes, 2003, 52 : 581 – 587. [DOI via Crossref]    [Pubmed]   
6. Giugliano D, Ceriello A, Paolisso G . Oxidative stress and diabetic vascular complications. Diabetes care, 1996, 19 : 257 – 267. [DOI via Crossref]    [Pubmed]   
7. Johnstone M.T., Creager S.J., Scales K.M., Cusco J.A., Lee B.K., Greager M.A. Impaired endothelium dependent vasodilation in patients with insulin dependent diabetes mellitus. Circulation, 1993, 88 :2510-2516. [DOI via Crossref]    [Pubmed]   
8. Sharma A, Simmi K, Chungh S, Kakkar R, Singh G. Effect of glycemic control and vitamin E supplementation on total glutathione content in NIDDM. Annuals of nutrition & metabolism, 2000, 44 : 11 – 13
9. Jacob S, Ruus P, Hermann R, Tritschler H.J., Maerker E, Renn W, Augustin H.J. et al. Oral administration of RAC – α – lipoic acid modulates insulin sensitivity in patients with Type 2 Diabetes Mellitus : a placebo controlled pilot trial. Free Radic Biol Med, 1999, 27 : 309 – 314. [DOI via Crossref]   
10. Vijayalingam S, Parthiban A, Shanmugasundaram K, Mohan V. Abnormal antioxidant status in impaired glucose tolerance and NIDDM. Diabetic Medicine,1996,12 : 715-719. [DOI via Crossref]   
11. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. New York, Oxford University Press, 1989.
12. Paolisso G, A D'Amore, D Galzerano, V Balbi, D Giugliano, M Varricchio et al. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly Type 2 Diabetes Mellitus patients. Diabetes care, 1993, 16 : 1433 – 1437. [DOI via Crossref]    [Pubmed]   
13. Paolisso G., A D ' Amore, V. Balbi, C. Volpe, D. Galzerano, D. Giugliano et al. Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetics. Am J Physiol Endocrinol Metab, 1994,266 : E261-E268.
14. Azzi A, Ricciarelli R, Zingg J.M. Non-antioxidant molecular functions of alpha-tocopherols (vitamin E).FBS Lett.,2002,519:8-10
15. Griffin M.E., Marcucci M.J., Cline G.W., Bell K, Barucci N, Lee D et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C and alterations in insulin signaling cascades. Diabetes, 1999, 48 : 1270-1274. [DOI via Crossref]    [Pubmed]   
16. Kowluru R.A., Kennedy A. Therapeutic potential of antioxidants and diabetic retinopathy. Expert Opin Investing Drugs, 2001, 10 : 1665 – 1676. [DOI via Crossref]    [Pubmed]   
17. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witzum J.L. Beyond cholesterol : modifications of LDL that increase its atherogenicity. N Engl J Med, 1989, 320 : 915-924. [DOI via Crossref]    [Pubmed]   
18. Andrew R, Skyrme-Jones P, O'Brien R.C., Berry K.L., Meredith I.T. Vitamin E supplementation improves endothelial functioin in Type 1 Diabetes Mellitus : a randomized placebo controlled study. J Am Coll Cardiol, 2000, 36 : 94-102. [DOI via Crossref]   
19. Bursell S.E., Clermont A.C., Aiello L.P., Schlossman D.K., Feener E.P., Laffel L. High dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patient with Type 1 Diabetes Mellitus. Diabetes Care, 1999, 22 : 1245-1251. [DOI via Crossref]    [Pubmed]   
20. Kuroki T, Isshiki K, and G.L. King. Oxidative stress : The lead or supporting actor in the pathogenesis of diabetic complications. J Am Soc Nephrol, 2003, 14 : 216-220. [DOI via Crossref]   

How to Cite this Article
Pubmed Style

Desai NK, Bhabhor PH, Domadia D, Bhatt JD. Role Of Antioxidant Therapy In Management Of Type 2 Diabetes Mellitus. NJIRM. 2013; 4(2): 128-133.



Web Style

Desai NK, Bhabhor PH, Domadia D, Bhatt JD. Role Of Antioxidant Therapy In Management Of Type 2 Diabetes Mellitus. www.scopemed.org/?mno=36925 [Access: October 18, 2017].



AMA (American Medical Association) Style

Desai NK, Bhabhor PH, Domadia D, Bhatt JD. Role Of Antioxidant Therapy In Management Of Type 2 Diabetes Mellitus. NJIRM. 2013; 4(2): 128-133.



Vancouver/ICMJE Style

Desai NK, Bhabhor PH, Domadia D, Bhatt JD. Role Of Antioxidant Therapy In Management Of Type 2 Diabetes Mellitus. NJIRM. (2013), [cited October 18, 2017]; 4(2): 128-133.



Harvard Style

Desai, N. K., Bhabhor, P. H., Domadia, D. & Bhatt, J. D. (2013) Role Of Antioxidant Therapy In Management Of Type 2 Diabetes Mellitus. NJIRM, 4 (2), 128-133.



Turabian Style

Desai, N K, P H Bhabhor, D Domadia, and J D Bhatt. 2013. Role Of Antioxidant Therapy In Management Of Type 2 Diabetes Mellitus. National Journal of Integrated Research in Medicine, 4 (2), 128-133.



Chicago Style

Desai, N K, P H Bhabhor, D Domadia, and J D Bhatt. "Role Of Antioxidant Therapy In Management Of Type 2 Diabetes Mellitus." National Journal of Integrated Research in Medicine 4 (2013), 128-133.



MLA (The Modern Language Association) Style

Desai, N K, P H Bhabhor, D Domadia, and J D Bhatt. "Role Of Antioxidant Therapy In Management Of Type 2 Diabetes Mellitus." National Journal of Integrated Research in Medicine 4.2 (2013), 128-133. Print.



APA (American Psychological Association) Style

Desai, N. K., Bhabhor, P. H., Domadia, D. & Bhatt, J. D. (2013) Role Of Antioxidant Therapy In Management Of Type 2 Diabetes Mellitus. National Journal of Integrated Research in Medicine, 4 (2), 128-133.



AUTHOR LOGIN

REVIEWER LOGIN

Indexed In

 National Journal of Integrated Research in Medicine

Publication by Association of Health Professionals and Health Educators

Open access peer reviewed Journal -  Publication Ethics Policies for Medical Journals  - Retracted Article 

    eISSN : 0975-9840, pISSN:  2230 - 9969 

Now Indexed in National Library of Medicine Catalog,

Indexed in PubMed (for Selected Citation)

Indexed in Index Medicus for the South-East Asian Region

Indexed in Index Copernicus (IC Value 66.37)

Search Your article in Index Copernicus

ISRA Journal Impact Factor: 5.39,  Scientific Journal Impact Factor = 2.507

WHO-HINARI, Index Scholar,

Science Central.com (Score 23.0)

 

  http://www.impactfactorservice.com/assets/images/logo.png     

Included in Open J-Gate, getCITED, connotea, Open Directory Project,

 EQUATOR Network,Ulrich’s Database of ProQuest, MedWorm Publisher,Connect Journals & EBSCO Publishing, ISC Database, New Jour, PSOAR Database, JournalSeek, ourGlocal Journal Database,Cochrane Menstrual Disorders and Subfertility Group, Islamic world science citation center,   

open access journals search engine, Impact Index, Journal Index,Citefactor.org, Directory of Research Journals Indexing (DRJI), Sjournals Index, Open Academic Journals Index, SIS database

 

 --------------------------------------------------------------------------------

List of Journals Indexed for MEDLINE

The List of Journals Indexed for MEDLINE publication ceased with the 2008 edition. The NLM Catalog can be used to obtain a list of currently indexed MEDLINE titles; select the Limit for Current Subsets called "Currently indexed in MEDLINE."

The List of Serials Indexed for Online Users online publication is designed to provide bibliographic information for serials from which articles are indexed with the MeSH® vocabulary and cited in MEDLINE®, the backbone of the NLM PubMed® database. More detailed bibliographic data and information about indexing coverage for serials cited in MEDLINE/PubMed can be found in LocatorPlus®, the NLM online catalog, and the NLM Catalog, an Entrez database.

Journals Recently Accepted by NLM for Inclusion in MEDLINE lists titles selected by LSTRC which meets three times per year in February, June, and October. Results from those meetings appear online about six weeks after each meeting, both on the Web page and in the NLM Catalog.

Previous print versions of the List of Journals Indexed for MEDLINE might be available from the U.S. Government Printing Office (GPO). Information about ordering documents from GPO is available at http://www.nlm.nih.gov/pubs/pubcat.html#ordering.

 
 



The articles in National Journal of Integrated Research in Medicine are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.